Geri Dön

Diabetes Mellituslu hastalarda plazma, lokosit ve eritrosit içi çinko, bakır ve magnezyum düzeyleri

Başlık çevirisi mevcut değil.

  1. Tez No: 29373
  2. Yazar: TEMİR ALİ DEMİR
  3. Danışmanlar: DOÇ. DR. EKİN ÖNDER
  4. Tez Türü: Doktora
  5. Konular: Biyokimya, Biochemistry
  6. Anahtar Kelimeler: Diabetes Mellitus, Zinc, Copper, Magnesium, Bakır, Magnezyum, Plazma, Çinko, Diabetes Mellitus, Zinc, Copper, Magnesium, Plasma
  7. Yıl: 1993
  8. Dil: Türkçe
  9. Üniversite: Anadolu Üniversitesi
  10. Enstitü: Fen Bilimleri Enstitüsü
  11. Ana Bilim Dalı: Kimya Ana Bilim Dalı
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: Belirtilmemiş.

Özet

vi SUMMARY We determined zinc, copper and magnesium levels in plasma from 39 patients with Type II Diabetes Mellitus (DM) and 50 healthy men by using Atomic Absorbtion Spectrophotometer. The concentrations of zinc, copper and magnesium in leucocytes and erythrocytes have also been measured after preparation as described by using modified Boyum's method. The mean plasma levels in controls are; Zn : X = 990 ± 162 \ig/l, Cu : X = 817 ± 134 jj.g/1, Mg : X = 21.24 ± 1.02 mg/1. The mean erythrocytes levels in controls are; Zn : X = 14.92 ± 2.85 ^ig/1010 cells, Cu : X = 0.933 ± 0.13 Hg/1010 cells, Mg : X = 53.88 ± 6.4 |ig/1010 cells. The mean leucocytes levels in controls are; Zn : X = 87.46 + 33 jig/10 10 cells, Cu : X = 16.14 ± 7.1 ng/1010 cells, Mg : X = 397 ± 107 ng/1010 cells. The mean results of plasma in Type II Diabetes Mellitus patients are;vü Zn : X = 1072 ± 147 ^ıg/1, Cu : X = 1129 ± 109 ng/1, Mg : X = 20.346 ± 1.12 mg/1. The mean results of erythrocytes in Type II Diabetes Mellitus patients are; Zn : X = 14.96 ±4.1 ^ig/1010 cells, Cu : X = 0.539 ± 0.12 iig/1010 cells, Mg : X = 42.67 ± 5.4 ^ig/1010 cells. The mean results of leucocytes in Type II Diabetes Mellitus patients are; Zn : X = 84.05 ± 33 ng/1010 cells, Cu : X = 12.36 ± 5.6 |ig/1010 cells, Mg : X = 352 ± 64 ng/1010 cells. By the statistical evaluation, zinc and copper concentrations are significantly higher (p>0.01 and p>0.0005 respectively) but magnesium concentrations are significantly lower (p>0.0005) and in erythrocytes zinc concentrations are insignificantly higher (p>0.4) but copper and magnesium concentrations are significantly lower (p>0.0005) and finally in leucocytes zinc concentrations are insignificantly lower (p<0.4) but copper and magnesium concentrations are significantly lower (p<0.0005 and p<0.025 respectively) in plasma from Type II Diabetes Mellitus patients than those in control groups. As a result, the variety between zinc, copper and magnesium levels in plasma leucocytes and erytrocytes might be significant due to clinical activity of Type II Diabetes mellitus patients. It has been suggested that erytrocyte and leucocyte element determinations should be performed together with plasma. In order to make a correct evaluation.

Özet (Çeviri)

vi SUMMARY We determined zinc, copper and magnesium levels in plasma from 39 patients with Type II Diabetes Mellitus (DM) and 50 healthy men by using Atomic Absorbtion Spectrophotometer. The concentrations of zinc, copper and magnesium in leucocytes and erythrocytes have also been measured after preparation as described by using modified Boyum's method. The mean plasma levels in controls are; Zn : X = 990 ± 162 \ig/l, Cu : X = 817 ± 134 jj.g/1, Mg : X = 21.24 ± 1.02 mg/1. The mean erythrocytes levels in controls are; Zn : X = 14.92 ± 2.85 ^ig/1010 cells, Cu : X = 0.933 ± 0.13 Hg/1010 cells, Mg : X = 53.88 ± 6.4 |ig/1010 cells. The mean leucocytes levels in controls are; Zn : X = 87.46 + 33 jig/10 10 cells, Cu : X = 16.14 ± 7.1 ng/1010 cells, Mg : X = 397 ± 107 ng/1010 cells. The mean results of plasma in Type II Diabetes Mellitus patients are;vü Zn : X = 1072 ± 147 ^ıg/1, Cu : X = 1129 ± 109 ng/1, Mg : X = 20.346 ± 1.12 mg/1. The mean results of erythrocytes in Type II Diabetes Mellitus patients are; Zn : X = 14.96 ±4.1 ^ig/1010 cells, Cu : X = 0.539 ± 0.12 iig/1010 cells, Mg : X = 42.67 ± 5.4 ^ig/1010 cells. The mean results of leucocytes in Type II Diabetes Mellitus patients are; Zn : X = 84.05 ± 33 ng/1010 cells, Cu : X = 12.36 ± 5.6 |ig/1010 cells, Mg : X = 352 ± 64 ng/1010 cells. By the statistical evaluation, zinc and copper concentrations are significantly higher (p>0.01 and p>0.0005 respectively) but magnesium concentrations are significantly lower (p>0.0005) and in erythrocytes zinc concentrations are insignificantly higher (p>0.4) but copper and magnesium concentrations are significantly lower (p>0.0005) and finally in leucocytes zinc concentrations are insignificantly lower (p<0.4) but copper and magnesium concentrations are significantly lower (p<0.0005 and p<0.025 respectively) in plasma from Type II Diabetes Mellitus patients than those in control groups. As a result, the variety between zinc, copper and magnesium levels in plasma leucocytes and erytrocytes might be significant due to clinical activity of Type II Diabetes mellitus patients. It has been suggested that erytrocyte and leucocyte element determinations should be performed together with plasma. In order to make a correct evaluation.

Benzer Tezler

  1. Tez No

    165784

    Nikotinamidin kötü kontrollü tip 2 diyabetik olgularda nötrofil fagositoz ve oksidatif burst aktivitesine etkileri

    The effect of nicotinamide on neutrophil phagocytosis and oxidative burst activity in poorly controlled type 2 diabetic patients

    ZEYNEP OŞAR

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2005

    Endokrinoloji ve Metabolizma Hastalıklarıİstanbul Üniversitesi

    İç Hastalıkları Ana Bilim Dalı

    PROF.DR. HASAN İLKOVA

  2. Tez No

    59663

    Diabetes mellituslu hastalarda eritrosit-plazma lipid peroksidasyonunun hemoreolojik parametrelerle ilişkisinin incelenmesi

    Investigation of relationship between erythrocyte-plasma lipid peroxidation and hemorheologic parameters in patients with diabetes mellitus

    MELTEM ERCAN

    Doktora

    Türkçe

    Türkçe

    1997

    Biyofizikİstanbul Üniversitesi

    Biyofizik Ana Bilim Dalı

    PROF.DR. SİNAN ÖNEN

  3. Tez No

    988412

    Adrenal adenomu olan hastalarda inflamatuvar belirteçler ile non-fonksıyone/fonksıyone adenom arasındakı ilişki

    The relationship between inflammatory markers and non-functioning/functioning adenomas in patients with adrenal adenoma

    MERVE DOĞRUOĞLU

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2026

    Endokrinoloji ve Metabolizma HastalıklarıAfyonkarahisar Sağlık Bilimleri Üniversitesi

    İç Hastalıkları Ana Bilim Dalı

    PROF. DR. SELVİHAN BEYSEL

  4. Tez No

    730786

    COVİD-19 enfeksiyonunun uzun dönem metabolik ve hematolojik etkilerinin retrospektif değerlendirilmesi

    Retrospective assessment of LONG-TERM metabolic and hematological effects of COVİD-19 infection

    BERFİN APARI

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2022

    İç HastalıklarıKütahya Sağlık Bilimleri Üniversitesi

    İç Hastalıkları Ana Bilim Dalı

    DR. ÖĞR. ÜYESİ SERTAŞ ERARSLAN

  5. Tez No

    608750

    Depresyon hastalarında kan akışkanlığı parametrelerinin incelenmesi

    Investigation of blood flow parameters in depression patients

    YASEMİN YILDIZ

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2019

    FizyolojiHacettepe Üniversitesi

    Fizyoloji Ana Bilim Dalı

    PROF. DR. NESLİHAN DİKMENOĞLU FALKMARKEN

Geri Dön